Target intelligence / Profile preview

SDA1 domain containing 1 pseudogene 2 (SDAD1P2)

Target
SDAD1P2
Molecular classification
Other (Pseudogene)
01

Overview

SDA1 domain containing 1 pseudogene 2 is classified as a **pseudogene** in humans. Pseudogenes are DNA sequences related to known genes but contain mutations that prevent their expression as functional proteins[3][7][8][10]. SDAD1P2 shares homology with the protein-coding SDA1 domain containing 1 (SDAD1) gene, which is involved in ribosomal subunit biogenesis, but SDAD1P2 itself is not functional and does not encode a protein[3][5][7][9]. As a pseudogene, SDAD1P2 does not serve as a therapeutic target and does not have biological, disease, or drug association information in major scientific resources. **Additional notes:** - **Is_incorrect = true:** The entry “SDA1 domain containing 1 pseudogene 2” is not a valid drug or therapeutic target; it is a pseudogene (nonfunctional gene remnant)[3][5][7][8]. It should not be included in lists of candidate targets for drug development or disease association unless emerging functional evidence is reviewed. - Pseudogenes in general have been studied for possible non-coding functions (such as microRNA sponges or regulatory RNAs), but this is rare and not established for SDAD1P2[6][8][10]. **Summary:** SDAD1P2 is a human pseudogene, not a protein, enzyme, transporter, or receptor, and it has no recognized function, disease association, or druggability. It should not be considered a therapeutic target[3][5][7][8].

02

Biological functions

None established; as a pseudogene, SDAD1P2 does not encode a functional protein[3][5][7].
03

Disease associations

None established for SDAD1P2 specifically; in general, most pseudogenes do not have a directly validated disease association, though rare exceptions exist for other pseudogenes[3][6][8][10].

Beyond the preview

Go deeper on SDA1 domain containing 1 pseudogene 2 (SDAD1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SDA1 domain containing 1 pseudogene 2 (SDAD1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call